Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Crohn Disease
Kelly C. Cushing, Peter Higgins
JAMA (2021) Vol. 325, Iss. 1, pp. 69-69
Open Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract
Jianan Zhang, Morgan E. Walker, Katherine Z. Sanidad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Miniaturized implantable temperature sensors for the long-term monitoring of chronic intestinal inflammation
Surabhi R. Madhvapathy, Matthew I. Bury, Larry Wang, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 8, pp. 1040-1052
Closed Access | Times Cited: 21
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches
Andy Acevedo-Román, Natalia Pagán-Zayas, Liz I. Velázquez-Rivera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9715-9715
Open Access | Times Cited: 18
Modulating the Microbiome for Crohn’s Disease Treatment
Rachael Gowen, Ahmed Gamal, Luca Di Martino, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 828-840
Open Access | Times Cited: 25
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
Silvio Danese, Remo Panaccione, Brian G. Feagan, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 9, Iss. 2, pp. 133-146
Closed Access | Times Cited: 24
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 10
Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis
Beatriz Gros, Jonathan Blackwell, Jonathan Segal, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 1030-1040
Open Access | Times Cited: 10
Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy
Jean‐Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 8, pp. 1668-1677
Open Access | Times Cited: 8
Hyperbaric Oxygen Therapy in the Treatment of Crohn’s Disease
Jure Krstulović, Goran Augustin, Ivan Romić, et al.
Healthcare (2025) Vol. 13, Iss. 2, pp. 128-128
Open Access | Times Cited: 1
Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 51
Advance toward isolation, extraction, metabolism and health benefits of kaempferol, a major dietary flavonoid with future perspectives
Yang Li, Yongchao Gao, Vivek K. Bajpai, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 16, pp. 2773-2789
Closed Access | Times Cited: 50
Gold‐Doped Covalent Organic Framework Reveals Specific Serum Metabolic Fingerprints as Point of Crohn's Disease Diagnosis
Chenjie Yang, Hailong Yu, Xufang Hu, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 45
Closed Access | Times Cited: 48
Contribution of adaptive immunity to human COPD and experimental models of emphysema
Farrah Kheradmand, Yun Zhang, David B. Corry
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1059-1093
Closed Access | Times Cited: 32
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, et al.
Canadian Journal of Gastroenterology and Hepatology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 30
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells
Alexander M. Scherbakov, Svetlana K. Vorontsova, Alvina I. Khamidullina, et al.
Investigational New Drugs (2023) Vol. 41, Iss. 1, pp. 142-152
Open Access | Times Cited: 21
Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review
Ye Liu, Jinjian Huang, Sicheng Li, et al.
Biomaterials Science (2023) Vol. 12, Iss. 4, pp. 837-862
Closed Access | Times Cited: 20
Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease
Er-jin Wang, Mingyue Wu, Zheng‐Yu Ren, et al.
Burns & Trauma (2023) Vol. 11
Open Access | Times Cited: 19
Fatty Acid Oxidation Promotes Apoptotic Resistance and Proinflammatory Phenotype of CD4+ Tissue-resident Memory T cells in Crohn’s Disease
Guanzhan Liang, Huang Jun-feng, Jing Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 6, pp. 939-964
Open Access | Times Cited: 6
Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases
Alkeiver S Cannon, Prakash Nagarkatti, Mitzi Nagarkatti
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 288-288
Open Access | Times Cited: 36
Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota
Fan Yang, Beibei Ni, Qiuli Liu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Advances in research on the effectiveness and mechanism of Traditional Chinese Medicine formulas for colitis-associated colorectal cancer
Xiunan Wei, Xiaohui Leng, Gongyi Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Nitric Oxide, Neutrophil/Lymphocyte, and Platelet/Lymphocyte Ratios as Promising Inflammatory Biomarkers in Complicated Crohn’s Disease: Outcomes of Corticosteroids and Anti-TNF-α Therapies
Imene Soufli, Abdelkrim Hablal, Samia Bessaad, et al.
Inflammation (2023) Vol. 46, Iss. 3, pp. 1091-1105
Closed Access | Times Cited: 13
The Impact of Crohn’s Perianal Fistula on Quality of Life: Results of an International Patient Survey
Antonino Spinelli, Henit Yanai, Paolo Girardi, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 13
A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace
Yi Chen, Jiaqi Zhang, Junling Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Increased mucin‐degrading bacteria by high protein diet leads to thinner mucus layer and aggravates experimental colitis
Lulu Chen, Jingyan Wang, Jun Yi, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 10, pp. 2864-2874
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top